Comparison of two quantitative polymerase chain reaction methods for detecting HER2/neu amplification

Journal of Molecular Diagnostics

Volumn 5, Issue 3, 2003, Pages 184-190

  Millson, Alison ^a   Suli, Arminda ^b   Hartung, Leah ^a   Kunitake, Steve ^c   Bennett, Ann ^c   Nordberg, Mary C Lowry ^d   Hanna, Wedad ^e   Wittwer, Carl T ^a,b   Seth, Arun ^e   Lyon, Elaine ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Arcturus Bioscience Inc   (United States)

^d Louisiana State University School of Medicine Shreveport   (United States)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN;

ARTICLE; BREAST TUMOR; CELL LINE; CLINICAL LABORATORY; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE AMPLIFICATION; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MOLECULAR PROBE; ONCOGENE NEU; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS;

EID: 0042065208     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60471-0     Document Type: Article

References (26)

1. Coussens L, Yang-Feng TL, Liao YC, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A, Ullrich A: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985, 230:1132-1139
2. Schechter AL, Hung MC, Vaidyanathan L, Wienberg RA, Yang-Feng TL, Francke U, Ullrich A, Coussens L: The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 1985, 229:976-978
3. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244:707-712
4. Borg A, Tandon AK, Sigurdsson H, Clark GM, Ferno M, Fuqua SA, Killander D, McGuire WL: HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res 1990, 50:4332-4337
5. Parkes HC, Lillycrop K, Howell A, Craig RK: C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis. Br J Cancer 1990, 61:39-45
6. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 253:177-182
7. Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Marckowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R, Paterson MC, Slamon DJ: Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res 1993, 53:4960-4970
8. Giai M, Roagna R, Ponzone R, De Bortoli M, Dati C, Sismondi P: Prognostic and predictive relevance of c-erbB-2 and ras expression in node-positive and -negative breast cancer. Anticancer Res 1994, 14:1441-1450
9. Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J: Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res 1998, 58:2825-283
10. Shak S: Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer: Herceptin Multinational Investigator Group. Semin Oncol 1999, 26:71-77
11. Burris III HA: Docetaxl (Taxotere) in HER-2-positive patients and in combination with trastuzumab (Herceptin). Semin Oncol 2000, 27: 19-23
12. Lyon E: Mutation detection using fluorescent hybridization probes and melting curve analysis. Exp Rev Mol Diagn 2001, 1:17-26
13. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP: Continuous fluorescent monitoring of rapid cycle DNA amplification. Biotechniques 1997, 22:130-138
14. Lyon E, Millson A, Lowery MC, Woods R, Wittwer CT: Quantification of HER2/neu gene amplification by competitive PCR using fluorescent melting curve analysis. Clin Chem 2001, 47:844-851
15. Persson K, Pandis N, Mertens F, Borg A, Baldetorp B, Killander D, Isola J: Chromosomal aberrations in breast cancer: a comparison between cytogenetics and comparative genomic hybridization. Genes Chromosomes Cancer 1999, 25:115-122
16. Wang S, Saboorian MH, Frenkel EP, Haley BB, Siddiqui MT, Gokaslan S, Hynan L, Ashfaq R: Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status. Mod Pathol 2002, 15:137-145
17. Bièche I, Olivi M, Champème, M-H, Vidaud D, Lidereau R, Vidaud M: Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer 1998, 78:661-666
18. Lyon E, Millson A, Suli A. HER2/neu gene amplification quantified by PCR and melting peak analysis using a single base alteration competitor as an internal standard. Rapid Cycle Real Time PCR: Methods and Application. Edited by Meuer S, Wittwer C, Nakagawara K. Heidelberg, Germany, Springer-Verlag, 2001, pp 207-217
19. Sestini R, Orlando C, Zentilin L, Donetella L, Gelmini S, Pinzani P: Gene amplification for cer-bB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template. Clin Chem 1995, 41:826-832
20. Hynes NE, Geber HA, Saurer S, Groner B: Overexpression of the c-erbB-2 protein in human breast tumor cell lines. J Cell Biochem 1989, 39:167-173
21. Dati C, Antoniotti S, Traverna D, Perroteau I, De Bortoli M: Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene 1990, 5:1001-1006
22. Thomas SM, Moreno RF, Tilzer LL: DNA: extraction with organic solvents in gel barrier tubes. Nucleic Acids Res 1989, 17:5411
23. Lay MJ, Wittwer CT: Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. Clin Chem 1997, 43:2262-2267
24. Bernard PS, Pritham GH, Wittwer CT: Color multiplexing hybridization probes using the apolipoprotein E locus as a model system for genotyping. Anal Biochem 1999, 273:221-228
25. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N: Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985, 230:1350-1354
26. Wittwer CT, Reed GB, Ririe KM: Rapid cycle DNA amplification. Polymerase Chain Reaction. Edited by Mullis KB, Ferré F, Gibbs RA. Boston, Birkhauser, 1994, pp 174-181